Tizanidine Hydrochloride

Product NDC
71335-0317
11-digit product format
713350317
Labeler code
71335
Product ID
71335-0317_93de2f10-747a-4518-85aa-de93552e1194
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tizanidine Hydrochloride
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA078868
Marketing category
ANDA
Marketing start
2012-02-06
Marketing end
0000-00-00
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
6 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-0317-17133503170130 CAPSULE, GELATIN COATED in 1 BOTTLE (71335-0317-1) 2015-04-240000-00-00NoNoCurrent
71335-0317-27133503170260 CAPSULE, GELATIN COATED in 1 BOTTLE (71335-0317-2) 2015-04-240000-00-00NoNoCurrent
71335-0317-37133503170390 CAPSULE, GELATIN COATED in 1 BOTTLE (71335-0317-3) 2015-04-240000-00-00NoNoCurrent
71335-0317-471335031704120 CAPSULE, GELATIN COATED in 1 BOTTLE (71335-0317-4) 2015-04-240000-00-00NoNoCurrent
71335-0317-57133503170528 CAPSULE, GELATIN COATED in 1 BOTTLE (71335-0317-5) 2015-04-240000-00-00NoNoCurrent